·
6 MIN READ

Sept. 6, 2019: State Advocacy Update

NY bills to increase access to MAT, advocating for pregnant opioid patients, and more in the latest of AMA's state advocacy updates.

Advocacy Update
Scales of justice
·
3 MIN READ

How CVS-Aetna case puts regulators on notice

The $69 billion deal was ultimately OK’d, but not before unprecedented legal scrutiny. Courts will no longer serve as a rubber stamp for megamergers.

Access to Care
·
2 MIN READ

Court ruling in CVS-Aetna merger leaves patients unprotected

Judicial decision ultimately fails patients.

Press Releases
·
3 MIN READ

July 25, 2019: Advocacy spotlight on Scrutiny of CVS-Aetna deal shows AMA's powerful impact

The scrutiny of CVS-Aetna deal shows AMA's powerful impact on the health care system. Learn more.

Advocacy Update
·
1 MIN READ

AMA statement on closing arguments in CVS-Aetna case

The CVS-Aetna merger and divestiture are not in the public interest, and the court should refuse to approve the antitrust settlement proposed by the DOJ.

Press Releases
Man in pharmacy looking at a prescription
·
3 MIN READ

Scrutiny of CVS-Aetna deal shows AMA’s powerful impact

The AMA has led opposition to the anti-competitive $69 billion mega-merger. Closing arguments in the matter take place in federal court tomorrow.

Access to Care
·
2 MIN READ

July 12, 2019: State Advocacy Update

Closing arguments in the CVS/Aetna case in the latest AMA state advocacy news.

Advocacy Update
·
3 MIN READ

June 14, 2019: Advocacy spotlight on CVS-Aetna merger: Not yet a final deal—AMA outlines competitive harm

The CVS-Aetna merger: Not yet a final deal. Find out how AMA outlines competitive harm.

Advocacy Update
·
14 MIN READ

AMA president applauds members moving medicine forward

In her address at the AMA Annual Meeting, AMA President Barbara L. McAneny today outlined a number of advocacy victories from the past year.

Press Releases